Shannon Aymes, MD, Author at Endocrinology Advisor

Obesity

Brain Structure Altered With Elevated BMI

By

Shannon Aymes, MD

May 6, 2016

Differences in cortical thickness were not seen in participants who were overweight or lean.

Cardiovascular and Metabolic Disorders

Exercise for Prevention of Heart Disease

By

Shannon Aymes, MD

February 26, 2016

Exercise’s potential positive effects on cardiovascular disease and heart failure may be possible regardless of frequency and time of initiation.

Androgen and Reproductive Disorders

Menopause Symptom Treatment Guideline Focuses on Individualized Approach

By

Shannon Aymes, MD

January 22, 2016

An individualized approach based on patient preferences is important for treatment of menopause.

Type 2 Diabetes

Meta-Analysis Compares Cardiometabolic Effects, Safety of Once-Weekly GLP-1 Receptor Agonists

By

Shannon Aymes, MD

December 11, 2015

A new review highlights a few differences among various once-weekly GLP-1 receptor agonists.

Obesity

Central Obesity May Raise Mortality Risk in Normal-Weight Individuals

By

Shannon Aymes, MD

November 18, 2015

Central obesity in people with normal weight may increase the risk for premature mortality vs BMI-defined overweight or obesity.

Diabetes

AACE/ACE Panel Supports Continued Use of SGLT2 Inhibitors in Diabetes

By

Shannon Aymes, MD

November 2, 2015

Expert panel recommends continued use of SGLT2 inhibitors, as risk for DKA is low.

Adrenal

Endocrine Society Releases Guidelines on Treatment of Cushing’s Syndrome

By

Shannon Aymes, MD

August 26, 2015

Guideline focuses on surgical resection to normalize cortisol levels.

A female athlete drinks water after exercising.

General Endocrinology

Exercise-Associated Hyponatremia: Prevention and Treatment Recommendations

By

Shannon Aymes, MD

July 21, 2015

Consensus group focuses on prevention and treatment of exercise-associated hyponatremia.

Shannon Aymes, MD

All articles by Shannon Aymes, MD

Brain Structure Altered With Elevated BMI

Exercise for Prevention of Heart Disease

Menopause Symptom Treatment Guideline Focuses on Individualized Approach

Meta-Analysis Compares Cardiometabolic Effects, Safety of Once-Weekly GLP-1 Receptor Agonists

Central Obesity May Raise Mortality Risk in Normal-Weight Individuals

AACE/ACE Panel Supports Continued Use of SGLT2 Inhibitors in Diabetes

Endocrine Society Releases Guidelines on Treatment of Cushing’s Syndrome

Exercise-Associated Hyponatremia: Prevention and Treatment Recommendations

Weight Gain Greater Among Breast Cancer Survivors